We are live on ! Find out more
MACK

Merrimack Pharmaceuticals, Inc.
MACK

Delisted

MACK was delisted on the 17th of May, 2024.

Back to rankings

Fund managers haven’t disclosed any holdings of MACK yet.

MACK Hedge Fund Activity: Q1 2025 in Review

1 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Merrimack Pharmaceuticals, Inc. (MACK) for Q1 2025, worth a combined $0 — down 100% from $371K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of MACK and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

  • 1 institutional investor held Merrimack Pharmaceuticals, Inc. (MACK) as of Q1 2025, down from 2 in Q4 2024.
  • Funds reported $0 of Merrimack Pharmaceuticals, Inc. stock for Q1 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Merrimack Pharmaceuticals, Inc. positions in Q1 2025 and 1 closed out, a net change of -1 holder.

Based on aggregated 13F filings for Q1 2025.